Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease

Investigation of the effects of rituximab (anti-CD20) on B-cell-activating factor of the tumor necrosis factor family (BAFF) and B cells would better define the significance of B-cell homeostasis in chronic graft-versus-host disease (cGVHD) pathophysiology. We studied 20 cGVHD patients at a median o...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Sarantopoulos, Stefanie, Stevenson, Kristen E., Kim, Haesook T., Washel, Whitney S., Bhuiya, Nazmim S., Cutler, Corey S., Alyea, Edwin P., Ho, Vincent T., Soiffer, Robert J., Antin, Joseph H., Ritz, Jerome
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2011
Teme:
Transplantation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3062333/
https://ncbi.nlm.nih.gov/pubmed/21097674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-10-307819
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items